ask="27.00"
ask_size="100"
average_daily_volume="38453"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="+0.02"
change_from_200_day_moving_average="-4.42"
change_from_50_day_moving_average="-3.03"
change_from_52_week_high="-11.94"
change_From_52_week_low="4.40"
change_in_percent="+0.14%"
close="14.42"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="7054000"
high="14.74"
high_52_weeks="26.36"
last_trade_date="2/27/2017"
last_trade_price="14.42"
last_trade_size="2097"
last_trade_time="4:00pm"
low="14.05"
low_52_weeks="10.02"
market_capitalization="241.02M"
moving_average_200_day="18.84"
moving_average_50_day="17.45"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="14.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.46%"
percent_change_from_50_day_moving_average="-17.37%"
percent_change_from_52_week_high="-45.30%"
percent_change_from_52_week_low="+43.91%"
previous_close="14.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="7.43"
stock_exchange="NGM"
symbol="PTGX"
volume="24078"
weeks_range_52="10.02 - 26.36"
